IL6R and neoplasm: Moreover, high expression of IL-6 receptor (IL-6R) was confirmed in PCCs and the activation of IL-6R-related pathway in tumor cells was associated with a poor outcome in resected pancreatic ductal adenocarcinoma [40, 41].